Humira generic availability, cost, and dosage
The Checkup by Singlecare
MARCH 8, 2024
It was FDA approved in August 2017 as a biosimilar, approved in 2021 as an interchangeable biosimilar, and became available in the United States in July of 2023. Yusimry (adalimumab-aqvh) Yusimry was FDA approved in December 2021 and became available in the United States in July 2023.
Let's personalize your content